MTNB icon

Matinas BioPharma

61 hedge funds and large institutions have $34.8M invested in Matinas BioPharma in 2020 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 13 increasing their positions, 8 reducing their positions, and 11 closing their positions.

Holders
61
Holders Change
-4
Holders Change %
-6.15%
% of All Funds
1.23%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
7
Increased
13
Reduced
8
Closed
11
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
CFS
51
CRA Financial Services
New Jersey
$8K 10,000
LA
52
Legacy Advisors
Pennsylvania
$8K 10,000 +10,000 New
Ameriprise
53
Ameriprise
Minnesota
$8K 10,950 +10,950 New
JC
54
JBF Capital
Colorado
$5K 6,765 +6,765 New
HFM
55
Hartford Financial Management
Connecticut
$2K 2,500
SPIA
56
Steward Partners Investment Advisory
New York
$2K 3,040
CAL
57
Capital Analysts LLC
Pennsylvania
$1K 1,264
Millennium Management
58
Millennium Management
New York
$37 48,608 -351,162 -88%
BNP Paribas Financial Markets
59
BNP Paribas Financial Markets
France
$19 25
BBA
60
Baker Bros. Advisors
New York
-2,096,375 Closed
Renaissance Technologies
61
Renaissance Technologies
New York
-267,000 Closed
Jane Street
62
Jane Street
New York
-257,888 Closed
CAG
63
Crestwood Advisors Group
Massachusetts
-142,500 Closed
Hudson Bay Capital Management
64
Hudson Bay Capital Management
Connecticut
-75,000 Closed
Russell Investments Group
65
Russell Investments Group
United Kingdom
-51,900 Closed
ECM
66
ExodusPoint Capital Management
New York
-21,076 Closed
GCP
67
GSA Capital Partners
United Kingdom
-19,209 Closed
ARTA
68
A.R.T. Advisors
New York
-13,359 Closed
SPC
69
Sigma Planning Corp
Michigan
-12,600 Closed
PA
70
Planning Alternatives
Michigan
-10,000 Closed
VFA
71
Valeo Financial Advisors
Indiana
$0 200
IA
72
IFP Advisors
Florida
TRCT
73
Tower Research Capital (TRC)
New York
$0 100
CFGS
74
Concourse Financial Group Securities
Alabama